Octagon Capital Advisors, founded by Dr. Ting Jia, is a New York-based hedge fund manager specializing in investments in the healthcare sector worldwide. The firm focuses particularly on companies headquartered in the United States, China, the European Union, and the United Kingdom, investing in securities and financial instruments tailored to the healthcare industry.
Ting Jia is the Founder of Octagon Capital Advisors, drawing on extensive experience from previous roles at Hillhouse Capital Management, BVF Partners L.P., McKinsey & Company, and Memorial Sloan Kettering Cancer Center. Ting Jia earned a PhD in Immunology from Weill Cornell Graduate School of Medical Sciences (2003-2008).
Octagon Capital Advisors, founded by Dr. Ting Jia, is a New York-based hedge fund Octagon Capital Advisors is a hedge fund managing assets for 6 clients, with discretionary assets under management totaling $951,771,000. Their most recent 13F filing for Q1 2024 reported holdings of $834,374,475 in managed 13F securities, with a top 10 holdings concentration of 55.44%. Apellis Pharmaceuticals Inc. represents Octagon Capital Advisors's largest holding, with 2,806,980 shares held.
